Monoamineoxidase inhibition and insulin sensitivity.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D004357:Drug Synergism; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D013006:Growth Hormone / Q000032:analysis; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology; D007003:Hypoglycemia / Q000139:chemically induced; D007328:Insulin / Q000494:pharmacology*; D007538:Isoniazid / Q000494:pharmacology; D008099:Liver / Q000201:enzymology; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology; D010624:Phenelzine / Q000494:pharmacology; D051381:Rats; D014191:Tranylcypromine / Q000494:pharmacology
D006834:Hydrazines; D007328:Insulin; D008996:Monoamine Oxidase Inhibitors; D014191:Tranylcypromine; D013006:Growth Hormone; D010293:Pargyline; D010624:Phenelzine; D007538:Isoniazid